Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Jeffrey SteinDirector | Ideaya BiosciencesIDYA | Open-market buy | 03/02 | 03/02 | 50,000 sh | $32.96 | $1,648,000 | +1168.0% |
Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 24/05/29 | 24/05/31 | 28,500 sh2 trades | $36.25avg. | $1,033,023.05 | −100.0% | |
Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 24/05/14–24/05/16 | 24/05/16 | 175,000 sh7 trades | $42.27avg. | $7,397,014.85 | −20.5% | |
Briseno Andres RuizSEE REMARKS | Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 24/02/09 | 24/02/13 | 2,000 sh | $46.02 | $92,040 | −7.5% |
Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 24/02/08–24/02/09 | 24/02/12 | 99,372 sh2 trades | $45.24avg. | $4,495,833.03 | −12.8% | |
Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 24/02/01 | 24/02/05 | 628 sh2 trades | $45.00avg. | $28,260.04 | −0.1% | |
Briseno Andres RuizSEE REMARKS | Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 24/01/22 | 24/01/24 | 2,000 sh | $42.03 | $84,060 | −7.0% |
Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 24/01/12–24/01/16 | 24/01/17 | 75,000 sh2 trades | $40.15avg. | $3,011,156.07 | −10.0% | |
Briseno Andres RuizSEE REMARKS | Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 24/01/12 | 24/01/17 | 2,000 sh | $38.01 | $76,020 | −6.6% |
Yujiro S. HataPresident and CEO | Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 23/12/15 | 23/12/19 | 75,000 sh | $35.03 | $2,627,250 | −10.0% |
Jason ThroneChief Legal Officer | Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 23/12/15 | 23/12/19 | 10,000 sh | $35.04 | $350,400 | −100.0% |
SEE REMARKS | Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 23/12/14 | 23/12/18 | 2,000 sh2 trades | $34.00avg. | $68,003.28 | −6.1% |
Jason ThroneChief Legal Officer | Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 23/11/03 | 23/11/07 | 5,163 sh | $30.09 | $155,354.67 | −100.0% |
Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 23/09/12 | 23/09/14 | 1,000 sh2 trades | $30.01avg. | $30,005 | −100.0% | |
Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 23/09/01–23/09/05 | 23/09/06 | 3,837 sh2 trades | $30.03avg. | $115,225.11 | −100.0% | |
Briseno Andres RuizSEE REMARKS | Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 23/09/01 | 23/09/06 | 2,000 sh | $30.01 | $60,020 | −5.8% |
Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 23/08/29 | 23/08/31 | 5,000 sh | $28.87 | $144,350 | −35.0% | |
Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 23/08/21 | 23/08/23 | 978 sh | $26.40 | $25,819.2 | −6.4% | |
Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 23/08/16–23/08/18 | 23/08/18 | 4,022 sh3 trades | $26.38avg. | $106,109.36 | −20.8% | |
Ideaya BiosciencesIDYA | Open-market sale10b5-1 plan | 23/08/09 | 23/08/11 | 2,500 sh | $25.05 | $62,625 | −11.5% |
